Page last updated: 2024-09-03

aaptamine and n(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid

aaptamine has been researched along with n(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid in 1 studies

Compound Research Comparison

Studies
(aaptamine)
Trials
(aaptamine)
Recent Studies (post-2010)
(aaptamine)
Studies
(n(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid)
Trials
(n(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid)
Recent Studies (post-2010) (n(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid)
460292306

Protein Interaction Comparison

ProteinTaxonomyaaptamine (IC50)n(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid (IC50)
Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1Homo sapiens (human)0.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmad, M; Bolin, D; Burghardt, C; Chen, S; Conde-Knape, K; Gillespie, P; Kochan, J; Le, N; Mennona, F; Mischke, S; Qian, Y; So, SS; Tannu, S; Wang, H1

Other Studies

1 other study(ies) available for aaptamine and n(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid

ArticleYear
Discovery of 1-arylcarbonyl-6,7-dimethoxyisoquinoline derivatives as glutamine fructose-6-phosphate amidotransferase (GFAT) inhibitors.
    Bioorganic & medicinal chemistry letters, 2011, Nov-01, Volume: 21, Issue:21

    Topics: Drug Discovery; Enzyme Inhibitors; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Inhibitory Concentration 50; Isoquinolines

2011